Eng Hooi Tan

ORCID: 0000-0003-4470-2736
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life
  • COVID-19 Clinical Research Studies
  • COVID-19 and healthcare impacts
  • Medication Adherence and Compliance
  • Colorectal Cancer Screening and Detection
  • Pharmaceutical Practices and Patient Outcomes
  • Economic and Financial Impacts of Cancer
  • Statistical Methods in Clinical Trials
  • COVID-19 epidemiological studies
  • Male Breast Health Studies
  • Vaccine Coverage and Hesitancy
  • BRCA gene mutations in cancer
  • Machine Learning in Healthcare
  • Genetic factors in colorectal cancer
  • HER2/EGFR in Cancer Research
  • Clinical Reasoning and Diagnostic Skills
  • Kawasaki Disease and Coronary Complications
  • Drug-Induced Hepatotoxicity and Protection
  • Influenza Virus Research Studies
  • Sepsis Diagnosis and Treatment
  • Advanced Causal Inference Techniques
  • Colorectal Cancer Treatments and Studies
  • SARS-CoV-2 and COVID-19 Research
  • Bipolar Disorder and Treatment

University of Oxford
2020-2025

Nuffield Orthopaedic Centre
2020-2025

Office for National Statistics
2021-2022

National University Health System
2016-2021

National University of Singapore
2009-2021

National University Hospital
2019

Purpose: The COVID-19 pandemic profoundly affected healthcare systems and patients. There is a need to comprehend the collateral effects of on non-communicable diseases. We examined impact short-term survival for common solid tumours, including breast, colorectal, head neck, liver, lung, oesophageal, pancreatic, prostate, stomach cancer in UK. Methods: This was population-based cohort study electronic health records from UK primary care Clinical Practice Research Datalink GOLD database. In...

10.2147/clep.s463160 article EN cc-by-nc Clinical Epidemiology 2024-06-01

Abstract Objective Patients with autoimmune diseases were advised to shield avoid coronavirus disease 2019 (COVID-19), but information on their prognosis is lacking. We characterized 30-day outcomes and mortality after hospitalization COVID-19 among patients prevalent diseases, compared hospital admissions similar seasonal influenza. Methods A multinational network cohort study was conducted using electronic health records data from Columbia University Irving Medical Center [USA, Optum...

10.1093/rheumatology/keab250 article EN cc-by Lara D. Veeken 2021-03-11

OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital treatments, and health outcomes among children adolescents diagnosed or hospitalized with coronavirus disease 2019 (COVID-19) to compare them in secondary analyses patients previous seasonal influenza 2017–2018. METHODS International network cohort using real-world data from European primary care records (France, Germany, Spain), South Korean claims US claims, hospital databases. We included and/or COVID-19 at...

10.1542/peds.2020-042929 article EN cc-by PEDIATRICS 2021-05-28

Routinely collected real world data (RWD) have great utility in aiding the novel coronavirus disease (COVID-19) pandemic response. Here we present international Observational Health Data Sciences and Informatics (OHDSI) Characterizing Associated Risks Your Baseline Disease In SARS-COV-2 (CHARYBDIS) framework for standardisation analysis of COVID-19 RWD.

10.2147/clep.s323292 article EN cc-by-nc Clinical Epidemiology 2022-03-01

ABSTRACT Objectives To characterize the demographics, comorbidities, symptoms, in-hospital treatments, and health outcomes among children/adolescents diagnosed or hospitalized with COVID-19. Secondly, to describe amongst previous seasonal influenza. Design International network cohort. Setting Real-world data from European primary care records (France/Germany/Spain), South Korean claims US hospital databases. Participants Diagnosed and/or COVID-19 at age <18 between January June 2020;...

10.1101/2020.10.29.20222083 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2020-10-30
Nicola L. Barclay Edward Burn Antonella Delmestri Talita Duarte‐Salles Asieh Golozar and 95 more Wai Yi Man Eng Hooi Tan Ilona Tietzova James N’Dow Wim P.J. Witjes Emma Jane Smith Carla Bezuidenhout Sarah Collen Karin Plass Torsten Blum Angelika Borkowetz Peter-Paul Willemse Philip Cornford Saeed Dabestani Maurice Schlief Juan Gómez Rivas Anders Bjartell M. Roobol Katharina Beyer Lionne D. F. Venderbos Sebastiaan Remmers Daan Nieboer Raoul Boomsma Bertrand De Meulder Charles Auffray Nesrine Taibi Ayman Hijazy Albert Saporta Johann Pellet Imran Omar Lesley Anderson Steven MacLennan Sara MacLennan Valerie Speirs Solveiga Zibaite Moragh Boyle Charlotte Murray Dianne Brown Demi McDonald Andres Metspalu Jaak Vilo Raivo Kolde Sulev Reisberg Elena Sügis Marek Oja Telver Objärtel Alberto Briganti Giorgio Gandaglia Martina Faticoni Greta Matteuzzi Claude Chelala Louise Jones Maryam Abdollahyan Emanuela Gadaleta Guido Juckeland Michael Bußmann Daniel Kotik Artur Yakimovich Torsten Bauer Jens Kollmeier Jessica Werchan Torsten Blum Rebecca Graebig-Rancourt Tobias Sjöblom Chatarina Larsson Arvid Widenlou Nordmark Daniel Prieto‐Alhambra Sara Khalid Edward Burn Antonella Delmestri Mahkameh Mafi Danielle Newby Cheryl Tan Nikolaus Forgó Antoni Napieralski Martina Wimmer Katharina Haimbuchner Saskia Kaltenbrunner K. Hartl Kseniia Guliaeva Giuseppe Curigliano Carmen Criscitiello Stefania Morganti Chiara Corti Elena Dal Zotto Nadia Harbeck Julian Koch Neal Navani Sam M. Janes Amyn Bhamani Stéphane Lejeune Mario Campone Jean‐Sébastien Frenel Kevin Joubel François Bocquet

Breast cancer is the most frequently diagnosed in females globally. However, we know relatively little about trends males. This study describes United Kingdom (UK) secular breast from 2000 to 2021 for both sexes. We describe a population-based cohort using UK primary care Clinical Practice Research Datalink (CPRD) GOLD and Aurum databases. There were 5,848,436 eligible 5,539,681 males aged 18+ years, with ≥ one year of prior data availability period. estimated crude incidence rates (IR),...

10.1038/s41598-024-69006-1 article EN cc-by Scientific Reports 2024-08-17

Menopausal Hormone Therapy (MHT) use in Australia fell by 55% from 2001 to 2005, following the release of large-scale findings on its risks and benefits. Comprehensive national data, including information overall prevalence MHT as well duration have not been reported since 2004–5 National Health Survey, when 11% women aged 45+ years were estimated be current users. No data are available “bioidentical” hormone therapy (BHT). The objective this study was determine recent BHT use. A...

10.1371/journal.pone.0146494 article EN cc-by PLoS ONE 2016-03-23

BackgroundMedication adherence is crucial for improving clinical outcomes in the treatment of patients. We evaluate effect short message service (SMS) reminder on medication and serum hormones patients with breast cancer aromatase inhibitors.MethodsAn open-label, multi-centre, prospective randomised controlled trial SMS versus Standard Care was conducted. Medication assessed via self-report using Simplified Adherence Questionnaire at baseline, 6 month, 1 year. Androstenedione, estradiol,...

10.1016/j.breast.2020.06.012 article EN The Breast 2020-07-02

Electronic Health Record (EHR) systems are digital platforms in clinical practice used to collect patients' information related their health status and represents a useful storage of real-world data. EHRs have potential role research studies, particular, platform trials. Platform trials innovative trial designs including multiple arms (conducted simultaneously and/or sequentially) on different treatments under single master protocol. However, the use comes with important challenges such as...

10.1016/j.jbi.2023.104553 article EN cc-by Journal of Biomedical Informatics 2023-11-22

Background In patients with uncontrolled asthma treated medium dose (md) inhaled corticosteroid/long-acting beta2 agonist (ICS/LABA), The Global Initiative for Asthma (GINA) recommends to increase high (hd) ICS/LABA or start therapy consisting of md ICS/LABA+LAMA (long-acting muscarinic antagonist). Adding LAMA on top hd is not recommended Step 4 patients, yet it used in the real world. Patient characteristics influencing treatment step-up are unknown. Objectives Identify determinants option...

10.1183/23120541.00869-2024 article EN cc-by-nc ERJ Open Research 2025-02-27

Background: The management of colorectal cancer (CRC) is evolving, with advances in screening and treatment. Objective: To leverage population-based data to generate up-to-date UK estimates age sex-specific incidence overall survival for the period 2000-2021. Design: We analysed nationally representative primary care records from Clinical Practice Research Datalink (CPRD) GOLD replicated CPRD Aurum. calculated rates, short- long-term stratified by age, sex, diagnosis year. Results: Overall...

10.14309/ajg.0000000000003460 article EN The American Journal of Gastroenterology 2025-04-01

Background: Pancreatic cancer is the seventh leading cause of related mortality worldwide and fifth in United Kingdom (UK), with incidence rates nearly matching mortality. Methods: We conducted a population-based cohort study using Clinical Practice Research Datalink (CPRD) GOLD Aurum databases including patients aged 18+ at least one year prior data, diagnosed between 2000 2021. estimated incidence, period prevalence, survival one, five, ten years, stratified by age, sex, calendar year....

10.1101/2025.04.08.25325482 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2025-04-10

Lung cancer is the leading cause of cancer-associated mortality worldwide. In United Kingdom (UK), there has been a major reduction in smoking, risk factor for lung cancer. Therefore, an up-to-date assessment trends required UK. This study aims to describe burden and terms incidence, prevalence, survival from 2000-2021, using two UK primary care databases.

10.21037/tlcr-24-241 article EN Translational Lung Cancer Research 2024-09-01

Abstract Evidence on the comparative effectiveness of osteoporosis treatments is heterogeneous. This may be attributed to different populations and clinical practice, but also differing methodologies ensuring comparability treatment groups before effect estimation amount residual confounding by indication. study assessed denosumab vs oral bisphosphonate (OBP) using propensity score (PS) methods negative control outcome (NCO) analysis. A total 280 288 women aged ≥50 yr initiating or OBP in...

10.1093/jbmr/zjae059 article EN cc-by Journal of Bone and Mineral Research 2024-04-15

We studied the characteristics of patients prescribed osteoporosis medication and patterns use in European databases. Patients were mostly female, older, had hypertension. There was suboptimal persistence particularly for oral medications. Our findings would be useful to healthcare providers focus their resources on improving specific treatments.To characterise therapy describe drug utilization patterns.We investigated treatment bisphosphonates, denosumab, teriparatide, selective estrogen...

10.1007/s00198-023-06837-0 article EN cc-by-nc Osteoporosis International 2023-07-12

Medication adherence refers to whether a patient takes medication according the frequency prescribed, or continues take prescribed medication. Inadequate may cause alterations in risk-benefit ratios, resulting reduced benefits, increased risks both, and is significantly associated with adverse clinical outcomes higher healthcare costs. We aim examine effect of computer generated short message service (SMS) reminder improving adherence, inhibiting aromatisation process amongst breast cancer...

10.1186/s12885-018-4660-7 article EN cc-by BMC Cancer 2018-07-09

Using real-world data and past vaccination data, we conducted a large-scale experiment to quantify bias, precision timeliness of different study designs estimate historical background (expected) compared post-vaccination (observed) rates safety events for several vaccines. We used negative (not causally related) positive control outcomes. The latter were synthetically generated true signals with incident rate ratios ranging from 1.5 4. Observed vs. expected analysis using within-database is...

10.3389/fphar.2021.773875 article EN cc-by Frontiers in Pharmacology 2021-11-24

ABSTRACT Objectives The COVID-19 pandemic profoundly affected healthcare systems and patients. There is a pressing need to comprehend the collateral effects of on noncommunicable diseases. Here we examined impact shortterm cancer survival in United Kingdom (UK). We hypothesised that short-term from nine cancers would be reduced during pandemic, particularly benefit screening early detection (e.g., breast colorectal cancer). Design Population-based cohort study. Setting Electronic health...

10.1101/2023.09.14.23295563 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2023-09-14

To derive outcome-based critical result thresholds in the adult patient population.We extracted deidentified laboratory results and outcomes (death or discharged) of patients 18 years older from Medical Information Mart for Intensive Care database. The lower upper were obtained nearest minimum maximum values, which corresponded to predicted probability death at 90%.The value sodium (<123, >153 mmol/L), potassium (<2.2, >6.6 bicarbonate (<15, >49 chloride (<82, >121 urea (>20 creatinine...

10.1093/ajcp/aqz026 article EN American Journal of Clinical Pathology 2019-02-20

Abstract Background: We described the demographics, cancer subtypes, comorbidities, and outcomes of patients with a history coronavirus disease 2019 (COVID-19). Second, we compared hospitalized COVID-19 to diagnosed influenza. Methods: conducted cohort study using eight routinely collected health care databases from Spain United States, standardized Observational Medical Outcome Partnership common data model. Three cohorts were included: (i) COVID-19, (ii) (iii) influenza in 2017 2018....

10.1158/1055-9965.epi-21-0266 article EN cc-by-nc-nd Cancer Epidemiology Biomarkers & Prevention 2021-07-16
Marta Pineda‐Moncusí Alexandros Rekkas Álvaro Martínez Pérez Ángela Leis Carlos López-Gómez and 95 more Eric Fey Erwin Bruninx Filip Maljković Francisco Sánchez-Sáez Jordi Rodeiro Loretta Kiss Michael Franz Miguel Ángel Mayer Neva Eleangovan Pau Pericas Pantelis Natsiavas Selçuk Şen Steven R. Cooper Sulev Reisberg Katrin Manlik Beatriz del Pino Albert Prats‐Uribe Ali Yağız Üresin Ana Danilović Bastić Ana Maria Rodrigues Ãngela Afonso Anna Palomar‐Cros Annelies Verbiest Antonella Delmestri Barış Erdoğan Carina Dinkel-Keuthage Carmen Olga Torre C. de Beukelaar Caroline Eteve‐Pitsaer Cátia F. Gonçalves C. Palma Cristina Gavina Daniel Dedman David Price Denisa Gabriela Balan Dirk Enders Edward Burn Elisa Henke Elyne Scheurwegs Emma Callewaert Maria E. Pérez-Martínez Eng Hooi Tan Fabian Praßer François Antonini Frank Staelens Fredrik Nyberg Geoffray Agard Giuseppe Galli Gianmario Candore Gianny Mestdach Hadas Shachaf Harri Rantala Huiqi Li Ines Reinecke Irene López-Sánchez Jaime E. Poquet-Jornet Javier de la Cruz Jelle Evers João Firmino‐Machado Jonas W. Wastesson Juan Luis Cruz-Bermúdez Juan Manuel Ramírez‐Anguita Kimmo Porkka Kristina Johnell Laurent Boyer Lieselot Cool Luca Moscetti Manon Merkelbach Mariana Canelas‐Pais Massimo Dominici Máté Szilcz Matteo Puntoni Mees Mosseveld Mina Tadrous Miquel Oltra-Sastre Mona Bové Nadav Rappoport Noelia García Barrio Otto Ettala Paolo Baili Paula Rubio-Mayo Peter Prinsen Raeleesha Norris Ravinder Claire Reut Sherman Yackob Roberto Lillini Salvador Garcia-Torrens Sampo Kukkurainen Silvia Lazzarelli Talita Duarte‐Salles Tiago Taveira‐Gomes Tim Jansen Ulrich Keilholz Wai Yi Man Xintong Li

Abstract Importance Drug shortages leave affected patients in a vulnerable position. Objective To describe incidence and prevalence of use for medicines with suggested at least one European country, as announced by the Medicines Agency, to characterise users these drugs including indication use, duration dosage. Design We performed descriptive cohort study from 2010 up 2024 network databases which have mapped their data Observational Medical Outcomes Partnership (OMOP) Common Data Model...

10.1101/2024.08.28.24312695 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2024-08-29
Coming Soon ...